Swiss National Bank Arvinas, Inc. Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

A detailed history of Swiss National Bank transactions in Arvinas, Inc. stock. As of the latest transaction made, Swiss National Bank holds 94,000 shares of ARVN stock, worth $1.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94,000
Previous 94,000 -0.0%
Holding current value
$1.79 Million
Previous $2.5 Million 7.47%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$24.46 - $40.4 $491,646 - $812,040
-20,100 Reduced 17.62%
94,000 $2.5 Million
Q1 2024

May 07, 2024
BUY
$36.38 - $52.31 $894,948 - $1.29 Million
24,600 Added 27.49%
114,100 $4.71 Million
Q4 2023

Feb 06, 2024
SELL
$14.19 - $42.33 $144,738 - $431,766
-10,200 Reduced 10.23%
89,500 $3.68 Million
Q3 2023

Nov 08, 2023
BUY
$19.64 - $28.21 $23,568 - $33,852
1,200 Added 1.22%
99,700 $1.96 Million
Q2 2023

Aug 09, 2023
BUY
$21.73 - $31.43 $19,557 - $28,287
900 Added 0.92%
98,500 $2.44 Million
Q1 2023

May 10, 2023
SELL
$26.15 - $37.26 $303,340 - $432,216
-11,600 Reduced 10.62%
97,600 $2.67 Million
Q4 2022

Feb 08, 2023
BUY
$32.47 - $57.24 $64,940 - $114,480
2,000 Added 1.87%
109,200 $3.74 Million
Q3 2022

Nov 09, 2022
BUY
$41.87 - $57.99 $54,431 - $75,387
1,300 Added 1.23%
107,200 $4.77 Million
Q2 2022

Aug 09, 2022
BUY
$36.01 - $74.24 $439,322 - $905,727
12,200 Added 13.02%
105,900 $4.46 Million
Q1 2022

May 09, 2022
BUY
$60.27 - $81.57 $753,375 - $1.02 Million
12,500 Added 15.39%
93,700 $6.31 Million
Q3 2021

Nov 08, 2021
BUY
$73.2 - $107.87 $190,320 - $280,462
2,600 Added 3.31%
81,200 $6.67 Million
Q2 2021

Aug 06, 2021
BUY
$60.45 - $84.26 $477,555 - $665,654
7,900 Added 11.17%
78,600 $6.05 Million
Q1 2021

May 07, 2021
BUY
$58.19 - $91.37 $46,552 - $73,096
800 Added 1.14%
70,700 $4.67 Million
Q4 2020

Feb 05, 2021
BUY
$20.19 - $84.93 $514,845 - $2.17 Million
25,500 Added 57.43%
69,900 $5.94 Million
Q3 2020

Nov 09, 2020
BUY
$22.99 - $36.34 $20,691 - $32,706
900 Added 2.07%
44,400 $1.05 Million
Q2 2020

Aug 05, 2020
BUY
$29.88 - $56.74 $170,316 - $323,418
5,700 Added 15.08%
43,500 $1.46 Million
Q1 2020

May 08, 2020
BUY
$33.0 - $54.5 $39,600 - $65,400
1,200 Added 3.28%
37,800 $1.52 Million
Q4 2019

Feb 06, 2020
BUY
$15.39 - $44.38 $240,084 - $692,328
15,600 Added 74.29%
36,600 $1.5 Million
Q2 2019

Aug 02, 2019
BUY
$15.96 - $23.8 $335,160 - $499,800
21,000 New
21,000 $462,000

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email